These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23177082)
21. CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America. Araque M; Millán B; Mendoza E; Salas M J Infect Dev Ctries; 2013 May; 7(5):432-5. PubMed ID: 23669435 [No Abstract] [Full Text] [Related]
22. Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains. Adamus-Białek W; Wawszczak M; Arabski M; Majchrzak M; Gulba M; Jarych D; Parniewski P; Głuszek S Virulence; 2019 Dec; 10(1):260-276. PubMed ID: 30938219 [TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. Croxall G; Hale J; Weston V; Manning G; Cheetham P; Achtman M; McNally A J Antimicrob Chemother; 2011 Nov; 66(11):2501-8. PubMed ID: 21862477 [TBL] [Abstract][Full Text] [Related]
24. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity data in support of nitrofurantoin three times per day. Amábile-Cuevas CF; Arredondo-García JL J Antimicrob Chemother; 2011 Jul; 66(7):1652-3. PubMed ID: 21525023 [No Abstract] [Full Text] [Related]
26. Coping with a stressful host. Thumbikat P Virulence; 2011; 2(3):175-6. PubMed ID: 21597321 [No Abstract] [Full Text] [Related]
27. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate. Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157 [No Abstract] [Full Text] [Related]
29. Non-lactose-fermenting uropathogenic Escherichia coli from dogs: virulence profile characterization. Siqueira FM; De Carli S; Lopes CE; Machado L; Vieira TR; Pöppl ÁG; Cardoso MRI; Zaha A Lett Appl Microbiol; 2021 May; 72(5):596-603. PubMed ID: 33524173 [TBL] [Abstract][Full Text] [Related]
30. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? Marrs CF; Zhang L; Foxman B FEMS Microbiol Lett; 2005 Nov; 252(2):183-90. PubMed ID: 16165319 [TBL] [Abstract][Full Text] [Related]
31. O-serogroups of multi-drug resistant cervicovaginal Escherichia coli harboring a battery of virulence genes. Paniagua-Contreras GL; Monroy-Pérez E; Solis RR; Cerón AB; García Cortés LR; Alonso NN; Camarillo DH; Arreygue LS; Domínguez-Trejo P; Velásquez CD; Vaca-Paniagua F; Uribe-García A; Vaca S J Infect Chemother; 2019 Jul; 25(7):494-497. PubMed ID: 30824302 [TBL] [Abstract][Full Text] [Related]
32. Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends. Ghosh A; Bandyopadhyay D; Koley S; Mukherjee M Appl Biochem Biotechnol; 2021 Jul; 193(7):2267-2296. PubMed ID: 33595784 [TBL] [Abstract][Full Text] [Related]
33. Occurrence of class 1 integrons in uropathogenic fluoroquinolone-resistant clinical Escherichia coli isolates from Jamaica. Stephenson SA; Brown PD APMIS; 2013 Mar; 121(3):226-31. PubMed ID: 23030058 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of adhesive genes among uropathogenic Escherichia coli strains isolated from patients with urinary tract infection in Mangalore. Shetty AV; Kumar SH; Shekar M; Shetty AK; Karunasagar I; Karunasagar I Indian J Med Microbiol; 2014; 32(2):175-8. PubMed ID: 24713907 [TBL] [Abstract][Full Text] [Related]
35. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Guglietta A Future Microbiol; 2017 Mar; 12():239-246. PubMed ID: 28262045 [TBL] [Abstract][Full Text] [Related]
36. Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis. Hadifar S; Moghoofei M; Nematollahi S; Ramazanzadeh R; Sedighi M; Salehi-Abargouei A; Miri A Jpn J Infect Dis; 2017 Jan; 70(1):19-25. PubMed ID: 27000462 [TBL] [Abstract][Full Text] [Related]
37. Comparison of virulence variations on MDCK monolayers by Escherichia coli isolated from acute lobar nephronia and acute pyelonephritis. Cheng CH; Su LH; Tsau YK; Lin TY New Microbiol; 2011 Jan; 34(1):65-72. PubMed ID: 21344148 [TBL] [Abstract][Full Text] [Related]
38. An exploratory study of dog park visits as a risk factor for exposure to drug-resistant extra-intestinal pathogenic E. coli (ExPEC). Ahmed LN; Price LB; Graham JP BMC Res Notes; 2015 Apr; 8():137. PubMed ID: 25886556 [TBL] [Abstract][Full Text] [Related]
39. The use of infrared spectroscopy and artificial neural networks for detection of uropathogenic Escherichia coli strains' susceptibility to cephalothin. Lechowicz L; Urbaniak M; Adamus-Białek W; Kaca W Acta Biochim Pol; 2013; 60(4):713-8. PubMed ID: 24432322 [TBL] [Abstract][Full Text] [Related]
40. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]